KALA GARTH: Open Payments
NPI 1124679501 · LAKEWOOD RANCH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 24 payments from 12 companies in 2025. Trend: 2023 $3,097 · 2024 $1,146 · 2025 $745
Food & beverage: $546Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $169 |
| Galderma Laboratories, L.P. | 2 | $130 |
| Eli Lilly and Company | 1 | $99 |
| Lilly USA, LLC | 3 | $76 |
| ABBVIE INC. | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Almirall LLC | 1 | $30 |
| Incyte Corporation | 1 | $27 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
Products named: TREMFYA, NEMLUVIO, TALTZ, Sotyktu, SKYRIZI, RINVOQ, Seysara, EBGLYSS.
Industry payments across FL — which companies pay providers there.
